SberMedII
Since 2020
Russia
Central Federal District of the Russian Federation
Moscow
121205, territory of Skolkovo Innovation Center, Bolshoi Boulevard, building 30, building 1, el/pom/rm 2/225/225-5
Content |
Owners
SberMedII LLC is an integrator of solutions using artificial intelligence (AI) technologies for medicine. SberMedII is part of the ecosystem Sberbank and combines the developments of the Sber Artificial Intelligence Laboratory, the CoBrain-Analytics project, National Technology Initiative (NTI) Skolkovo Institute of Science and Technology to further introduce innovative technologies into the system. health care Russia
Tasks solved with the help of AI: support for medical decision-making, assistance in making a diagnosis - the second opinion, quality control of medical care, reducing the risks of missing pathologies and erroneous diagnoses.
History
2024: Recertification for compliance with the requirements of GOST R ISO 9001-2015, GOST ISO 13485-2017
SberMedII (part of the health industry of Sber) has developed and implemented a system Quality Management (QMS). The company successfully audited and updated the certificate compliance with the requirements of GOST R ISO 9001-2015, GOST ISO 13485-2017 in relation to a development computer software that is an independent medical device with artificial intelligence technology.
The certificate is issued by a national certification body registered in the Rosaccreditation system. After an independent audit, established compliance with the requirements of GOST R standards introduced in SberMedII QMS ISO 9001-2015, GOST ISO 13485-2017.
The presence of a valid QMS at the manufacturer of medical devices is one of the mandatory regulatory requirements for circulation medical products on the territory of the Russian Federation. Submit medical devices for registration according to the third only certified companies are eligible for the potential risk class.
{{quote 'author = said Sergei Zhdanov, Director of the Health Industry Center of Sberbank. | Certificate of compliance with the requirements of the quality management system shows that business processes in SberMedII correspond to everything necessary regulatory requirements. The company has developed and implemented a guide to quality, standards for control of procurement and manufactured products were adopted. The current QMS is an indicator of the quality of the developed AI solutions and forms trust in our products based on artificial intelligence with parties of the medical community, representatives of the health care system and the industry regulator,}}
2022
Change of head
The SberMedII company, which develops and implements services based on artificial intelligence for healthcare, replaced the CEO in early December 2022. It was Vladimir Koch. He succeeded Igal Zuk. Read more here.
Opening of MDDC Monitoring Center in Skoltech
On June 9, 2022, SberMedII announced the opening of an expert monitoring center for the Medical Digital Diagnostic Center (MDDC) on the territory of the Skolkovo Institute of Science and Technology (Skoltech).
The expert monitoring center is designed to manage and coordinate the platform. Statistics data from clinics in 43 regions, preliminary conclusions, processed, AI results of online verification from all consultant doctors also come here daily. More than 30 doctors of the first and highest qualification category work remotely with the platform; in the expert monitoring center, four highly qualified doctors coordinate the work of all MDDC consultant doctors and analyze the most difficult cases that require expert assessment.
The Medical Digital Diagnostic Center for June 2022 combines more than 50 products and solutions of SberMedII and partners based on artificial intelligence, including the smart assistant doctor "TOP-3," "CT of the Lungs," "CT Stroke" and others. MDDC was created to help doctors make diagnoses and make medical decisions based on data from primary admission, instrumental and laboratory diagnostics. On the platform, doctors can receive consultations and assistance in a large range of areas: therapy, cardiology, radiology, oncology, surgery. The platform supports the doctor at all stages of work: from processing research by artificial intelligence, to obtaining a medical opinion from a consultant doctor at an expert center.
Since the beginning of 2022, more than 400 thousand instrumental studies have been analyzed by AI algorithms, more than 6.5 thousand studies have been received for processing by MDDC doctors.
{{quote 'author = said Alexander Petrovich Kuleshov, rector of Skoltech. | The MDDC Expert Monitoring Center is a hybrid medical opinion site combining physician qualifications and advanced artificial intelligence technologies. This effective approach saves people's lives. For example, the advanced CT of the Lungs algorithm, which is built into MDDC, helps doctors detect cancer in the early stages. This is a real achievement that significantly increases the chances of a favorable prognosis of the course of the disease. The opening of the MDDC monitoring expert center on the territory of the Skolkovo Institute of Science and Technology is an important step that allows introducing AI-based services into the real practice of doctors throughout the country,}}
2021
AI from SberMedII will be used to optimize remote diagnostics on Canon equipment
SberMedII, API Canon Medical Systems and R-Farm signed agreements of intent in June 2021 on the joint development of projects in the field of digital diagnostics in medicine. Within the framework of the agreements, services and solutions with artificial intelligence from SberMedII will be used to optimize remote diagnostics obtained on the equipment of Canon and Fujifilm manufacturers, also using the best laboratory solutions from R Farm partners.
The implementation of a new approach to digital diagnostics, namely, the integration of algorithms based on artificial intelligence with diagnostic and laboratory equipment will reduce capital costs for the healthcare system and significantly increase the effectiveness of diagnostic measures.
Plan for the integration of the Care Mentor AI neural network system into the SberMedII ecosystem
SberMedII and the Russian developer of neural network platforms LLC KeremtorAi (Care Mentor AI) have agreed to launch joint projects to digitalize Russian healthcare. This was reported on January 29, 2021 by Sberbank.
The ecosystem for the development of AI health care Russia in - SberMedII - not only offers its own services in healthcare, but also unites the developments of Russian companies. The first open market participant to join the ecosystem is Care Mentor AI, LLC. The developed neural network system Care Mentor АI for determining pathologies of the chest will be integrated into the SberMedII ecosystem and will soon become available to users. More. here
2020: SberMedII is an ecosystem operator for the development of AI in healthcare in Russia
The Sber Group and the Skolkovsky Institute of Science and Technology on December 28, 2020 announced the signing of an agreement on the creation of an ecosystem for the development of artificial intelligence in Russian healthcare. The operator will be the SberMedII company created in the summer of 2020.
The ecosystem combines the development of Skoltech's scientific teams with the cloud engineering infrastructure of Sberbank and will become the technological foundation for creating services in healthcare. It is assumed that developers will have access to new capabilities for working with algorithms, an exclusive set of structured medical data, as well as tools for their processing.
The combined library of applications and data sets to help make medical decisions, formed on the basis of the developments of Sberbank and the CoBrain Skoltech project, is one of the largest in Russia. The main contribution to it was made as part of the implementation by Skoltech of the project of the National Technological Initiative "Development of an information and analytical system for the processing of large neurodata to support the introduction of NeuroNet technologies" CoBrain-Analytics "" in 2016-2020.
The range of medical solutions placed on the platform ranges from analysis of fluorographic images and radiographs to the detection of depression according to structural MRI data, and is constantly replenished.
SberMedII and Skoltech are developing medical solutions based on 50 artificial intelligence models. The services are already used by healthcare institutions in 16 Russian regions, where more than 40 million people live.
In particular, SberMedII has launched a system for supporting medical solutions, which is based on algorithms developed by the Sberbank Artificial Intelligence Laboratory. With this system, the doctor receives a second opinion on possible diagnoses. In the Moscow, Tambov, Orenburg regions, the Republic of Buryatia and the Krasnodar Territory, the service "CT of the lungs" is piloted, which allows you to determine the pathologies of the lungs, including those caused by COVID-19.
The use of modern technologies in healthcare is decisive for the quality of medical care and its availability, and serves the interests of the medical community and patients. The company ("SberMedII" - editor's note TAdviser) has gathered extra-class specialists who will help to take a serious step in the development of healthcare, - said Olga Golodets, Deputy Chairman of the Board of Sberbank PJSC. |
In the scientific world, there is a consensus on one statement: the greatest practical effect in AI applications should be expected in the field of medicine in the near future. We have every reason to believe that SberMedII will make a significant contribution to this industry. I would like to separately thank the leaders of Sberbank and NTI, without whom this work, of course, would not have taken place, - stressed Alexander Kuleshov, rector of Skoltech. |
SberMedII is in the process of signing agreements with Russian companies, which will create the largest medical AI market in Russia. We strive to combine all advanced AI solutions for healthcare on one platform, - said Igal Zuk, project manager at CoBrain Analytics Skoltech, CEO of SberMedII. |
The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |